Hemopoietic engraftment after allogeneic peripheral blood transplantation:: A comparison of CD34+ selected (allo-PBT/CD34+) with unmanipulated (allo-PBT) grafts.

被引：0
|
作者：
Riu, C [1 ]
Urbano-Ispizua, A [1 ]
Martínez, C [1 ]
Rovira, M [1 ]
Perales, M [1 ]
Marín, P [1 ]
Lozano, M [1 ]
Ocejo, A [1 ]
Rozman, C [1 ]
Carreras, E [1 ]
Montserrat, E [1 ]
机构：
[1] Hosp Clin Barcelona, Dept Haematol, Barcelona, Spain
来源：
BONE MARROW TRANSPLANTATION | 1999年 / 23卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
67
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [1] Allogeneic transplantation of CD34+selected cells from peripheral blood (allo-PBT/CD34+) in patients with myeloid malignancies in early phase:: A case control comparison with unmanipulated peripheral blood transplants (allo-PBT).
    Urbano-Ispizua, A
    Brunet, S
    Solano, C
    de la Rubia, J
    Odriozola, J
    Zuazu, J
    Caballero, D
    Ferré, C
    Riu, C
    García, J
    Sanz, G
    Torrabadella, M
    Pérez-Oteiza, J
    Jurado, M
    Oyonarte, S
    Sierra, J
    García-Conde, J
    Rozman, C
    Montserrat, E
    [J]. BLOOD, 1999, 94 (10) : 609A - 609A
  • [2] Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation (allo-PBT):: Comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts.
    Martínez, C
    Urbano-Ispizua, A
    Rozman, C
    Marín, P
    Rovira, M
    Sierra, J
    Montfort, N
    Carreras, E
    Montserrat, E
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 : S112 - S112
  • [3] Endogenous production of cytokines in autologous (auto-PBT) and allogeneic CD34+ selected peripheral blood stem cell transplantation (allo-PBT).
    Vizcarra, E
    Solano, C
    Marugan, I
    Benet, I
    Arbona, C
    García-Conde, J
    [J]. BLOOD, 1998, 92 (10) : 295B - 295B
  • [4] Allogeneic peripheral blood transplantation (allo-PBT) with CD34+ positive selection and reduction of pharmacological GVHD prophylaxis.
    Solano, C
    Gutiérrez, A
    Arbona, C
    Benet, I
    Marugan, I
    Prósper, F
    Terol, MJ
    Tormo, M
    Garcia-Conde, J
    [J]. BLOOD, 1998, 92 (10) : 318B - 318B
  • [5] Allogeneic peripheral blood transplantation (Allo-PBT) with CD34+ positive selection and reduction of pharmacological GHVD prophylaxis.
    Solano, C
    Gutiérrez, A
    Arbona, C
    Benet, I
    Marugan, I
    Prósper, F
    Terol, MJ
    Tomo, M
    García-Conde, J
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S19 - S19
  • [6] Quantitative assessment of chimerism in neutrophils and T-cells after allogeneic CD34+selected Peripheral Blood Cell Transplants (allo-PBT/CD34+).: A prospective comparison with unmodified Allogeneic Stem Cell Transplants (Allo-SCT).
    Fernández-Avilés, F
    Urbano-Ispizua, A
    Aymerich, M
    Colomer, D
    Martínez, C
    Rovira, M
    Carreras, E
    Montserrat, E
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S227 - S228
  • [7] Serial quantification of mixed chimerism of T-cells and myeloid cells predicts graft rejection and relapse, respectively, after allogeneic CD34+ selected peripheral blood cell transplants (ALLO-PBT/CD34+).
    Fernández-Avilés, F
    Urbano-Ispizua, A
    Aymerich, M
    Colomer, D
    Rovira, M
    Martínez, C
    Carreras, E
    Montserrat, E
    [J]. BLOOD, 2001, 98 (11) : 190A - 190A
  • [8] Predictive factors for graft versus host disease after allogeneic transplantation of CD34+selected cells from peripheral blood (allo-PBT/CD34+) from HLA-identical siblings.
    Urbano-Ispizua, A
    Pimentel, P
    Solano, C
    de la Rubia, J
    Brunet, S
    Odriozola, J
    Ferrá, C
    Zuazu, J
    Caballero, D
    Torres, P
    Díez, JL
    Espigado, I
    Rovira, M
    Campilho, F
    Grañena, A
    Sanz, G
    Riu, C
    Figuera, A
    Carvalhais, A
    Perez-Oteiza, J
    Oyonarte, S
    Sierra, J
    Garcia-Conde, J
    Montserrat, E
    [J]. BLOOD, 2000, 96 (11) : 396A - 396A
  • [9] The number of donor CD3+cells is the most important factor for graft failure after allogeneic transplantation of CD34+selected cells from peripheral blood (allo-PBT/CD34+) from HLA-identical siblings.
    Urbano-Ispizua, A
    Rozman, C
    Pimentel, P
    Solano, C
    de la Rubia, J
    Brunet, S
    Pérez-Oteiza, J
    Ferrá, C
    Zuazu, J
    Caballero, D
    Carvalhais, A
    Díez, JL
    Espigado, I
    Martínez, C
    Campilho, F
    Sanz, MA
    Sierra, J
    García-Conde, J
    Montserrat, E
    [J]. BLOOD, 2000, 96 (11) : 345B - 345B
  • [10] The number of donor CD34+and CD3+cells is the most important factor for disease free survival (DFS) after allogeneic transplantation of CD34+selected cells from peripheral blood (allo-PBT/CD34+) from HLA-identical siblings.
    Urbano-Ispizua, A
    Solano, C
    de la Rubia, J
    Brunet, S
    Pimentel, P
    Odriozola, J
    Ferrá, C
    Zuazu, J
    Caballero, D
    Torres, P
    Díez, JL
    Espigado, I
    Carreras, E
    Campilho, F
    Arranz, R
    Perez-Oteiza, J
    Sierra, J
    Garcia-Conde, J
    Montserrat, E
    [J]. BLOOD, 2000, 96 (11) : 397A - 397A
12345